ABN Clinical Research Training Fellowships 2027: Salaried Neurology Research Training With Up to £10,000 a Year for Fees and Research Costs

ABN Clinical Research Training Fellowships 2027: Salaried Neurology Research Training With Up to £10,000 a Year for Fees and Research Costs

The Association of British Neurologists (ABN) 2027 Clinical Research Training Fellowship round is closed. The cycle-specific ABN application page is labelled “Applications Closed” and gives a closing time of 23:59 on 20 September 2026. ABN’s broader opportunities page still carries generic “applications now open” wording for the 2027 fellowships; the dated, cycle-specific application page is the controlling notice for this round. The ABN has not announced a later round on that page, so this entry is a historical reference to the 2027 cycle, not an open application listing. Do not use the dates or application materials below as a current call; check the ABN website for any future announcement.

The closed scheme was for doctors building a career in neurology who sought protected time for a higher degree in Clinical Neuroscience. Successful applicants could receive up to three years of salary support at their current NHS basic clinical salary point, together with up to £10,000 per year toward university fees and approved research costs. This specialist clinical-academic award was not a general postgraduate scholarship. It supported research intended to advance understanding, diagnosis, treatment, or care for people living with neurological disease.

The 2027 application period opened on 9 July 2026. Shortlisted applicants were scheduled for virtual interviews on 2 December 2026, and fellowship commencement was to be by September 2027. Those are dates for the completed 2027 cycle only.

Key details

The page also identifies one PSP Association Clinical Research Training Fellowship with funding of up to £350,000 over a maximum of three years for research on progressive supranuclear palsy and related conditions. That is a named partner-funded opportunity within the 2027 scheme, not a guarantee that every applicant can claim the larger figure. Applicants should match their proposal to the specific funder and read the current terms before describing the award in a budget.

What the fellowship supports

The central benefit is a salaried period in which a neurology trainee can complete research connected to a higher degree. The ABN describes the scheme as supporting the next generation of clinician-researchers and says that the research should advance the understanding, diagnosis, treatment, and care of neurological disease. In practical terms, the award can make a doctoral or equivalent research period financially viable by keeping salary support connected to the applicant’s clinical training level while also contributing to fees and approved research expenses.

The salary element matters because a research fellowship is not simply a tuition waiver. The award is calculated at the applicant’s current NHS or equivalent basic clinical salary point. The 2026 terms also provide for employer National Insurance and pension contributions, so the institutional costing should distinguish salary from these employment on-costs. Applicants should confirm the appropriate pay point and costing with their employer or training administrator before preparing a budget. The additional allowance is capped at £10,000 per year. The terms identify degree fees, conference and travel costs, equipment, and consumables among the eligible cost types; wider research costs must be met from other sources and declared. The allowance should not be presented as unrestricted personal income or as a substitute for every cost in a clinical research project.

The scheme can cover up to three years. The official page also allows a two- to three-year fellowship where the applicant has already completed up to one year of eligible research that can count toward the higher degree. That makes the programme relevant to people at slightly different points in their research journey, but it does not remove the need to explain what work remains, how long it will take, and why the requested duration is reasonable.

The 2027 round includes awards supported by the ABN and its funding partners. The Guarantors of Brain and Patrick Berthoud Charitable Trust track welcomes applications across Clinical Neuroscience. The Motor Neurone Disease Association track is for research aligned with understanding, diagnosis, treatment, and care of motor neurone disease. The PSP Association track is focused on progressive supranuclear palsy and related conditions. A proposal does not become a disease-specific application merely because it mentions a condition in passing; its research question and likely contribution should genuinely fit the relevant funder.

Who can apply

The ABN gives two main routes into eligibility. Applicants should be clinically qualified and either already hold a UK or Irish Neurology specialist training post before completion of training, or be able to demonstrate a clear intention to enter Neurology specialist training after completing the fellowship. The terms describe early postgraduate applicants as needing to show a clear commitment and trajectory toward obtaining a neurology training number. This wording is important for applicants who are not yet in a specialist training post. They need to show a credible path into neurology rather than assume that a general medical background alone is enough.

The award is aimed at clinician-researchers, not at applicants seeking an unrelated laboratory studentship or a general international scholarship. The proposed higher degree must be in Clinical Neuroscience, and the project should have a clear benefit for people with neurological disease. The terms require the primary supervisor to be an ABN member when that supervisor is a neurologist. If the proposed primary supervisor is not a neurologist, the application must explain how clinical training will be supervised during the research period. A strong eligibility check therefore includes clinical qualification, current training status or intended training route, degree structure, supervisor arrangements, host institution, and clinical relevance.

The official page linked the 2027 application form and terms and directed applicants to upload the completed form through its submission form. The public summary did not set out a broader nationality or age rule. It specifically named UK or Irish neurology specialist training posts, or a clear intention to enter Neurology specialist training after the fellowship, as the routes into eligibility.

The 2027 page does not describe a broad nationality or age rule in the public summary. It does specifically refer to UK or Irish specialist training posts or a clear intention to enter Neurology specialist training. If your training arrangement is outside that wording, contact ABN before submitting rather than relying on an informal interpretation. The official application page and current terms control the final eligibility decision.

Research fit and partner-funded routes

A useful first test is whether the proposal connects clinical neuroscience to a neurological problem that matters to patients. The connection can be through disease mechanisms, diagnosis, treatment, prognosis, service delivery, rehabilitation, prevention, or care, but the application should make the path explicit. “Interesting neuroscience” is not enough if the proposal never explains how the work could improve knowledge or care.

The second test is whether the research can be completed within the requested fellowship period. A project that depends on a new cohort, a complex intervention, multiple sites, or a long follow-up period may still be viable, but the application must separate work already secured from work that is still aspirational. State what data, samples, clinical access, equipment, and supervisory expertise are already available.

The third test is partner alignment. The general ABN and Guarantors of Brain/Patrick Berthoud route is broad across Clinical Neuroscience. The MND Association and PSP Association routes are narrower. If a proposal genuinely fits a disease-specific track, explain the fit in the opening summary and in the expected patient benefit. Do not reshape a project artificially to fit a named charity: reviewers can usually see when the disease focus is decorative rather than central.

The public page does not publish a complete scoring rubric in its summary. Applicants should therefore avoid claiming that a particular weighting is official. A sensible preparation framework is to make the scientific question, feasibility, applicant development, supervisor environment, and likely clinical value easy to find. Those are practical signals of a fellowship-ready project, not a substitute for reading the ABN terms and application form.

Timeline and application route for the closed round

The ABN opened the 2027 call on 9 July 2026 and closed submissions at 23:59 on 20 September 2026. The official page says applicants had to complete the application form and upload it through the submission form on the fellowship page. It also lists the 2027 Fellowship Application Form and ABN Fellowship Terms and Conditions as downloadable materials. These details document how the completed round worked; they do not indicate that submissions remain possible.

The application form and terms were the controlling documents for applicants in that cycle. Applicants needed to read the terms, complete the 2027 form, and upload the completed application using the submission form linked on the ABN page. The terms say the requested duration had to be justified against the higher-degree timetable, and applications for less than two years were not accepted. They also specify supervisor membership or clinical-training supervision arrangements. Because the public page does not preserve a complete list of every form field, this archive does not try to reconstruct a checklist beyond the requirements stated in the official call and terms.

Shortlisted applicant interviews were scheduled virtually for 2 December 2026. Fellows were expected to commence by September 2027. Those dates describe selection and start arrangements for this cycle. The application page does not announce a subsequent call. Anyone looking for a new opportunity should check the ABN fellowship page for a fresh notice and use only the form and terms attached to that future round.

Materials applicants prepared for the 2027 round

Applicants needed a coherent project plan explaining the clinical problem, research question, proposed method, expected output, and relevance to patients or services. The ABN form controlled the required format; a one-page project map could help applicants keep their answers consistent, but it was a preparation aid rather than a separately stated requirement.

The budget needed to distinguish salary support and employer on-costs from the annual allowance for approved research costs. Applicants were asked to use the appropriate NHS or equivalent basic clinical salary point. The terms identify degree fees, conference and travel costs, equipment, and consumables as costs that may be requested within the £10,000 annual cap. Wider research costs had to be met through other sources and declared; the allowance did not imply that every institutional overhead or clinical cost would be covered.

The proposed primary supervisor’s contribution was relevant to eligibility and feasibility. Under the terms, a neurologist serving as primary supervisor had to be an ABN member. If the primary supervisor was not a neurologist, the application needed to specify arrangements for clinical-training supervision during the research period. Applicants also needed to make the project’s support and delivery arrangements credible, including access to the required data or patients and an environment capable of supporting the degree.

Applicants could support their readiness with relevant clinical experience, prior research, publications, audits, methods training, pilot results, or work already completed. Useful evidence named the work, described the applicant’s contribution, and explained what it demonstrated. The goal was to connect experience to the proposed project rather than provide a CV narrative detached from the research plan.

What made an application stronger in the 2027 round

Make the project legible to more than one neurological sub-specialty. A reviewer may understand the broad clinical issue without being a specialist in every technique. Define technical terms, explain why the comparison or measurement matters, and describe what a useful result would change. If the project is exploratory, say what decision the results will inform rather than promising a treatment breakthrough.

Show that the work is appropriately sized for the award. Break the project into stages with a sensible order: preparation, approvals, recruitment or data access, analysis, writing, and dissemination. Identify dependencies and contingency plans. A plan that acknowledges a recruitment risk is more convincing than one that assumes every participant, sample, or dataset will arrive on schedule.

Treat the patient benefit as a chain of reasoning. Explain the current problem, the information the project will generate, the person or service that could use it, and the next step after the fellowship. Do not claim that a laboratory finding will immediately change care unless that pathway is supported. Clinical relevance can be valuable without pretending that a three-year training project will solve an entire disease area.

For a disease-specific partner route, put the alignment in concrete terms. Explain why the research is relevant to motor neurone disease, progressive supranuclear palsy, or the general Clinical Neuroscience remit, depending on the application. If the project could fit more than one route, ask ABN how the funding decision is handled and do not submit conflicting versions without guidance.

Common mistakes to avoid

For the 2027 cycle, one avoidable mistake would have been treating 20 September as a date to begin rather than finish the upload. The closing time was 23:59, and the application required a completed form plus an online submission. The round is now closed; this reminder is retained as context for the process, not as an invitation to submit late.

Another mistake is describing the award as a flat £350,000 fellowship. The ABN page says that one PSP-focused fellowship may have funding of up to £350,000 over a maximum of three years. The general scheme provides salary support at the current NHS basic clinical salary point and up to £10,000 per year for fees and approved research costs. Use the amount that matches the route you are actually pursuing.

Applicants also needed to distinguish eligibility from competitiveness. Holding a qualifying training post did not make a project automatically fundable. A proposal still needed a defensible question, a capable supervisor, appropriate methods, a feasible timetable, and a clear reason the fellowship was the right next step.

The ABN may publish future fellowship rounds, but the 2027 page does not give a date for another call. Do not rely on the 2027 form or terms for a later cycle. Applicants considering a future round should locate its own current documents, particularly if they have applied before, already started a PhD, or are considering a disease-specific funding route.

Frequently asked questions

Was this a fully funded PhD?

The 2027 scheme offered salary support and an annual contribution toward university fees and approved research costs for up to three years, with the exact award depending on the application and funding route. It did not establish that every possible university or project cost would be covered.

Could someone who was not yet in neurology training apply?

The ABN said applicants could demonstrate a clear intention to enter Neurology specialist training after completing the fellowship. For an applicant whose route was not obvious from their current role, confirming eligibility with ABN before submitting would have been prudent.

Did the award last exactly three years?

The round offered up to three years. The page also described two- to three-year fellowships where up to one year of eligible research had already been completed and could count toward a higher degree.

What is the general research area?

Clinical Neuroscience and research that advances understanding, diagnosis, treatment, or care for neurological disease. Some 2027 places have narrower partner-funded themes for motor neurone disease or progressive supranuclear palsy and related conditions.

Is the 2027 round still open?

No. The official ABN page labels the 2027 applications closed. Its deadline was 23:59 on 20 September 2026, and shortlisted applicant interviews were scheduled virtually for 2 December 2026. ABN has not announced another round on the page. Check its fellowship page for future calls rather than treating this archived cycle as open.

Where can I find the official record?

The official ABN 2027 Fellowship Application page contains the closed-round notice and links to the 2027 application form, terms and conditions, and submission area. Direct access may return an HTTP error in some automated checks; the ABN page remains the canonical source. For any future opportunity, use the ABN’s current announcement and documents.

Official links and next steps

The ABN 2027 Clinical Research Training Fellowship application page is the primary record for this closed round. It identifies the 2027 scheme as closed and documents the eligibility, funding, dates, partner routes, and application materials described here. The ABN’s fellowship overview provides wider programme context. Neither page currently announces a new application cycle. Prospective applicants should monitor ABN announcements and confirm all future deadlines, amounts, eligibility rules, and forms against the next official call.

As a historical opportunity, the 2027 scheme is useful for understanding the ABN’s recent approach: salary support tied to a clinical pay point, a capped annual contribution to fees and approved research costs, neurology training eligibility, and partner funding for defined research remits. Those features should not be assumed to carry over unchanged. A future round may revise its partners, amounts, assessment process, or timetable, so researchers and supervisors should treat this page as an archive of the previous cycle rather than a live funding notice.